Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma

BACKGROUND AND PURPOSE: Pre-treatment ADC characteristics have been shown to predict response to bevacizumab in recurrent glioblastoma multiforme. However, no studies have examined whether ADC characteristics are specific to this particular treatment. The purpose of the current study was to determin...

詳細記述

保存先:
書誌詳細
出版年:AJNR Am J Neuroradiol
主要な著者: Ellingson, B.M., Sahebjam, S., Kim, H.J., Pope, W.B., Harris, R.J., Woodworth, D.C., Lai, A., Nghiemphu, P.L., Mason, W.P., Cloughesy, T.F.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Neuroradiology 2014
主題:
Brain
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7965805/
https://ncbi.nlm.nih.gov/pubmed/24136647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3748
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料